GRIFFIN; Graeme

Patent Applications and Registrations

Patent applications and USPTO patent grants for GRIFFIN; Graeme.The latest application filed is for "biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors".

Company Profile

0.10.9

GRIFFIN; Graeme - Farmingdale NY
Griffin; Graeme - Buffalo Grove IL US
Griffin; Graeme - Centereach NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biological Markers Predictive Of Anti-cancer Response To Epidermal Growth Factor Receptor Kinase Inhibitors App 20160158235 - HALEY; John D. ; et al.	2016-06-09
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors Grant 9,244,058 - Haley , et al. January 26, 2	2016-01-26
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Grant 8,586,546 - Buck , et al. November 19, 2	2013-11-19
Combined Treatment with an EGFR Kinase Inhibitor and an Agent that Sensitizes Tumor Cells to the Effects of EGFR Kinase Inhibitors App 20120207767 - Buck; Elizabeth A. ; et al.	2012-08-16
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors App 20120157480 - Haley; John D. ; et al.	2012-06-21
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Grant 8,114,846 - Buck , et al. February 14, 2	2012-02-14
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors Grant 8,093,011 - Haley , et al. January 10, 2	2012-01-10
Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease Grant 7,879,566 - Griffin , et al. February 1, 2	2011-02-01
Combined Treatment With An Egfr Kinase Inhibitor And An Agent That Sensitizes Tumor Cells To The Effects Of Egfr Kinase Inhibitors App 20100166776 - Buck; Elizabeth A. ; et al.	2010-07-01
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Grant 7,651,687 - Buck , et al. January 26, 2	2010-01-26
Methods for the Identification of Modulators of OSGPR114 or OSGPR78 Activity, and their use in the Treatment of Disease App 20090274684 - Griffin; Graeme ; et al.	2009-11-05
Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease Grant 7,524,638 - Griffin , et al. April 28, 2	2009-04-28
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors App 20070286864 - Buck; Elizabeth A. ; et al.	2007-12-13
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors App 20070280928 - Buck; Elizabeth A. ; et al.	2007-12-06
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors App 20060211060 - Haley; John D. ; et al.	2006-09-21
Methods for identification of modulators of OSGPR116 activity, and their use in the treatment of disease App 20060199229 - Griffin; Graeme	2006-09-07
Methods for identification of modulators of OSGPR116 activity Grant 7,083,933 - Griffin August 1, 2	2006-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.